George C Eckert Ii

Array ( [id] => 6402844 [patent_doc_number] => 20100305192 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-12-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR SHORT INTERFERING NUCLEIC ACID INHIBITION OF NAV1.8' [patent_app_type] => utility [patent_app_number] => 12/789564 [patent_app_country] => US [patent_app_date] => 2010-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15780 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0305/20100305192.pdf [firstpage_image] =>[orig_patent_app_number] => 12789564 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9989634 [patent_doc_number] => 09034838 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-19 [patent_title] => 'miR-31 in duchenne muscular dystrophy therapy' [patent_app_type] => utility [patent_app_number] => 13/322023 [patent_app_country] => US [patent_app_date] => 2010-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4859 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13322023 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8653068 [patent_doc_number] => 08372817 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-02-12 [patent_title] => 'Small interfering RNA for gene knockdown of the subcutaneous N-methyl-D-aspartate receptor NR1 subunit, and it\'s application on pharmaceutics' [patent_app_type] => utility [patent_app_number] => 12/780278 [patent_app_country] => US [patent_app_date] => 2010-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 7216 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12780278 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026464 [patent_doc_number] => 20110054005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same' [patent_app_type] => utility [patent_app_number] => 12/662904 [patent_app_country] => US [patent_app_date] => 2010-05-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 35839 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054005.pdf [firstpage_image] =>[orig_patent_app_number] => 12662904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8211567 [patent_doc_number] => 20120129912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-24 [patent_title] => 'RNA Targeting in Alpha-Synucleinopathies' [patent_app_type] => utility [patent_app_number] => 13/319022 [patent_app_country] => US [patent_app_date] => 2010-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6687 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20120129912.pdf [firstpage_image] =>[orig_patent_app_number] => 13319022 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8629910 [patent_doc_number] => 08361982 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-01-29 [patent_title] => 'Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell' [patent_app_type] => utility [patent_app_number] => 12/769157 [patent_app_country] => US [patent_app_date] => 2010-04-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 32 [patent_no_of_words] => 22094 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 100 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12769157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6026474 [patent_doc_number] => 20110054006 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-03-03 [patent_title] => 'REGULATION OF ONCOGENES BY MICRORNAS' [patent_app_type] => utility [patent_app_number] => 12/767724 [patent_app_country] => US [patent_app_date] => 2010-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 38 [patent_no_of_words] => 26314 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20110054006.pdf [firstpage_image] =>[orig_patent_app_number] => 12767724 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9676677 [patent_doc_number] => 08815586 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-08-26 [patent_title] => 'Modulation of gene expression using oligomers that target gene regions downstream of 3′ untranslated regions' [patent_app_type] => utility [patent_app_number] => 12/766574 [patent_app_country] => US [patent_app_date] => 2010-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 32781 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12766574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8128525 [patent_doc_number] => 20120088811 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-12 [patent_title] => 'METHOD FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA' [patent_app_type] => utility [patent_app_number] => 13/138914 [patent_app_country] => US [patent_app_date] => 2010-04-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6449 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20120088811.pdf [firstpage_image] =>[orig_patent_app_number] => 13138914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6097934 [patent_doc_number] => 20110162979 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'Method and Apparatus for Forming of an Automated Sampling Device for the Detection of Salmonella Enterica Utilizing an Electrochemical Aptamer Biosensor' [patent_app_type] => utility [patent_app_number] => 12/764828 [patent_app_country] => US [patent_app_date] => 2010-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 12743 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0162/20110162979.pdf [firstpage_image] =>[orig_patent_app_number] => 12764828 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199603 [patent_doc_number] => 20120122957 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'REGULATION OF AGING BY MODULATION OF MITOCHONDRIAL FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/264939 [patent_app_country] => US [patent_app_date] => 2010-04-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 18398 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122957.pdf [firstpage_image] =>[orig_patent_app_number] => 13264939 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8095953 [patent_doc_number] => 20120083522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'MODULATION OF INFLAMMATORY RESPONSES BY FACTOR XI' [patent_app_type] => utility [patent_app_number] => 13/262904 [patent_app_country] => US [patent_app_date] => 2010-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 67917 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0083/20120083522.pdf [firstpage_image] =>[orig_patent_app_number] => 13262904 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8054125 [patent_doc_number] => 20120076781 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'METHODS OF TREATING CANCERS WITH HER3 ANTISENSE OLIGONUCLEOTIDES' [patent_app_type] => utility [patent_app_number] => 13/264265 [patent_app_country] => US [patent_app_date] => 2010-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 28531 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0076/20120076781.pdf [firstpage_image] =>[orig_patent_app_number] => 13264265 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8328852 [patent_doc_number] => 08236942 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-07 [patent_title] => 'SiRNA targeting glucagon receptor (GCGR)' [patent_app_type] => utility [patent_app_number] => 12/798906 [patent_app_country] => US [patent_app_date] => 2010-04-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 43 [patent_figures_cnt] => 43 [patent_no_of_words] => 34727 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12798906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8689962 [patent_doc_number] => 08389489 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Modulators of coagulation factors' [patent_app_type] => utility [patent_app_number] => 12/758565 [patent_app_country] => US [patent_app_date] => 2010-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 19 [patent_no_of_words] => 23603 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12758565 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8241014 [patent_doc_number] => 20120149756 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-06-14 [patent_title] => 'TRICYCLO-DNA ANTISENSE OLIGONUCLEOTIDES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF DISEASE' [patent_app_type] => utility [patent_app_number] => 13/263949 [patent_app_country] => US [patent_app_date] => 2010-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 17748 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 28 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13263949 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6600492 [patent_doc_number] => 20100292305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'RNAi MODULATION OF HIF-1 AND THERAPUTIC USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/753650 [patent_app_country] => US [patent_app_date] => 2010-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16427 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20100292305.pdf [firstpage_image] =>[orig_patent_app_number] => 12753650 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8186876 [patent_doc_number] => 20120115927 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-10 [patent_title] => 'PHARMACEUTICAL AGENT FOR PREVENTING CELL DEATH' [patent_app_type] => utility [patent_app_number] => 13/259351 [patent_app_country] => US [patent_app_date] => 2010-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2408 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20120115927.pdf [firstpage_image] =>[orig_patent_app_number] => 13259351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6234844 [patent_doc_number] => 20100266548 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-10-21 [patent_title] => 'LPS-Responsive CHS1/Beige-Like Anchor Gene and Therapeutic Applications Thereof' [patent_app_type] => utility [patent_app_number] => 12/727378 [patent_app_country] => US [patent_app_date] => 2010-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 24868 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0266/20100266548.pdf [firstpage_image] =>[orig_patent_app_number] => 12727378 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7757157 [patent_doc_number] => 20120029055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-02 [patent_title] => 'MODULATORS OF APOPTOSIS AND THE USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/257228 [patent_app_country] => US [patent_app_date] => 2010-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 17028 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20120029055.pdf [firstpage_image] =>[orig_patent_app_number] => 13257228 [rel_patent_id] =>[rel_patent_doc_number] =>)